Literature DB >> 27851845

Society of Thoracic Surgeons Score Variance Results in Risk Reclassification of Patients Undergoing Transcatheter Aortic Valve Replacement.

Toby Rogers1, Edward Koifman2, Nirav Patel2, Jiaxiang Gai2, Rebecca Torguson2, Paul Corso2, Ron Waksman2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27851845      PMCID： PMC5470408          DOI： 10.1001/jamacardio.2016.4132

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  4 in total

1.  A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement.

Authors:  Davide Capodanno; Marco Barbanti; Corrado Tamburino; Paola D'Errigo; Marco Ranucci; Gennaro Santoro; Francesco Santini; Francesco Onorati; Claudio Grossi; Remo Daniel Covello; Piera Capranzano; Stefano Rosato; Fulvia Seccareccia
Journal:  Am J Cardiol       Date:  2014-03-18       Impact factor: 2.778

2.  The multiparametric FRANCE-2 risk score: one step further in improving the clinical decision-making process in transcatheter aortic valve implantation.

Authors:  Henrique B Ribeiro; Josep Rodés-Cabau
Journal:  Heart       Date:  2014-04-23       Impact factor: 5.994

3.  Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.

Authors:  James B Hermiller; Steven J Yakubov; Michael J Reardon; G Michael Deeb; David H Adams; Jonathan Afilalo; Jian Huang; Jeffrey J Popma
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

4.  Outcomes following transcatheter aortic valve replacement in the United States.

Authors:  Michael J Mack; J Matthew Brennan; Ralph Brindis; John Carroll; Fred Edwards; Fred Grover; David Shahian; E Murat Tuzcu; Eric D Peterson; John S Rumsfeld; Kathleen Hewitt; Cynthia Shewan; Joan Michaels; Barb Christensen; Alexander Christian; Sean O'Brien; David Holmes
Journal:  JAMA       Date:  2013-11-20       Impact factor: 56.272
  4 in total
  5 in total

1.  Unmet issues in transcatheter aortic valve implantation.

Authors:  Rodrigo Bagur
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Comparison of outcomes after transcatheter aortic valve implantation following home versus non-home discharge.

Authors:  Katherine R Hebeler; Gerald Ogola; Giovanni Filardo; Michael Mack; Robert Stoler; Timothy Mixon; Molly Szerlip; James Edgerton; Robert F Hebeler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-16

3.  Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice: Findings From EXTEND-CoreValve.

Authors:  Neel M Butala; Eric Secemsky; Dhruv S Kazi; Yang Song; Jordan B Strom; Kamil F Faridi; J Matthew Brennan; Sammy Elmariah; Changyu Shen; Robert W Yeh
Journal:  JACC Cardiovasc Interv       Date:  2021-10-11       Impact factor: 11.075

4.  Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease.

Authors:  Paweł Czub; Andrzej Cacko; Monika Gawałko; Emanuel Tataj; Jakub Poliński; Kacper Pawlik; Romuald Cichoń; Piotr Hendzel
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 5.  Transcatheter Aortic Valve Replacement in Intermediate- and Low-Risk Patients.

Authors:  Toby Rogers; Vinod H Thourani; Ron Waksman
Journal:  J Am Heart Assoc       Date:  2018-05-12       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.